Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5354549

C[N+]1(C)CCCN(c2ccc(N)cc2)CC1.[Cl-]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.56
KMT2A Q03164 3/20 0.56
KDM4E B2RXH2 3/20 0.56
GAA P10253 3/20 0.56
ALDH1A1 P00352 3/20 0.56
ALOX15 P16050 2/20 0.56
HSD17B10 Q99714 2/20 0.56
MEN1 O00255 2/20 0.56
POLB P06746 2/20 0.56
HTT P42858 2/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
NPC1 O15118 1/20 0.56
USP2 O75604 1/20 0.56
TP53 P04637 1/20 0.56
THRB P10828 1/20 0.56
RECQL P46063 1/20 0.56
RAB9A P51151 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
MAPK1 P28482 2/20 0.55
CYP3A4 P08684 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5391533 0.98 MAPT (0.59) MAPTKMT2AKDM4EGAAALDH1A1
SCHEMBL6748684 0.98 MAPT (0.58) MAPTKMT2AKDM4EGAAALDH1A1
Hydrochloric Acid SCHEMBL5350629 0.93 ALOX15 (0.62) MAPTKMT2AKDM4EGAAALDH1A1
Hydrochloric Acid SCHEMBL5345900 0.91 ALOX15 (0.60) MAPTKMT2AKDM4EGAAALDH1A1
SCHEMBL6743986 0.91 ALOX15 (0.64) MAPTKMT2AKDM4EGAAALDH1A1
SCHEMBL10114942 0.80 CHRNA7 (0.85) KMT2AALOX15HSD17B10MEN1POLB
Hydrochloric Acid SCHEMBL5410468 0.80 GAA (0.52) MAPTKMT2AGAAALDH1A1ALOX15
SCHEMBL6151460 0.79 ADRB1 (0.50) MAPTKMT2AKDM4EGAAALDH1A1
Iodide SCHEMBL404487 0.79 MEN1 (0.85) KMT2AALOX15HSD17B10MEN1POLB
SCHEMBL6746057 0.78 GAA (0.54) MAPTKMT2AGAAALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7186277-B2 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring L'OREAL SA (FR) 2007-03-06 US claimed
US-20040237216-A1 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring L'OREAL S.A. (FR) 2004-12-02 US claimed
US-7186277-B2 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring L'OREAL SA (FR) 2007-03-06 US disclosed
US-20040237216-A1 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring L'OREAL S.A. (FR) 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040237216-A1 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring KRT18, CDC73, DSP MAPT 2272/4885KMT2A 948/4885KDM4E 391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.